Merus and Biohaven Announce Collaboration to Co-Develop Three Novel Bispecific ADC Programs
Under the terms of the agreement, Biohaven is responsible for the preclinical ADC generation of three Merus bispecific antibodies under mutually agreed research plans. The agreement includes two Merus ...
NUS Pilots First-in-Market Green Bond Reporting Tokenisation Initiative with Northern Trust and UOB
NDAQ:NTRS) NUS Pilots First-in-Market Green Bond Reporting Tokenisation Initiative with Northern Trust and UOB ...
Natera Announces Preliminary Fourth Quarter and Full-Year Results for 2024
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today released preliminary unaudited results for the fourth quarter and full year ended December 31, 2024. The ...
Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025
NDAQ:CRBU) Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025 ...
Exact Sciences Announces Preliminary Fourth Quarter 2024 Results
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company expects to report revenue of $713 million for the fourth quarter ...
WuXi AppTec Joins the Pharmaceutical Supply Chain Initiative (PSCI)
WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life sciences industries, announced that it has joined the ...
Visa Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - V
NYSE:V) Visa Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - V ...
Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
Following closing of its transaction with Telix Pharmaceuticals, ImaginAb, Inc. will be focused on developing its lead imaging candidate, CD8 ImmunoPET, which is currently in Phase 2 clinical trials ...
CRBU Investors Have Opportunity to Lead Caribou Biosciences, Inc. Securities Fraud Lawsuit
NEW YORK, Jan. 12, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Caribou Biosciences, Inc. (NASDAQ: CRBU) between July 14, 2023 and July ...
Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings
A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com, in the "Investors" section under the "News and Events" page. A replay of the conference webcast will ...
Ascendis Pharma Provides Business and Strategic Roadmap Update at 43rd Annual J.P. Morgan Healthcare Conference
NDAQ:ASND) Ascendis Pharma Provides Business and Strategic Roadmap Update at 43rd Annual J.P. Morgan Healthcare Conference ...
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Match Group, Inc.(MTCH) Shareholders
NDAQ:MTCH) Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Match Group, Inc.(MTCH) Shareholders ...